RECRUITING
I'm interested ...!!
Cardiovascular Disease Risk in Women With Endometriosis
To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.
Conditions:
🦠 Endometriosis
🗓️ Study Start (Actual) 1 July 2022
🗓️ Primary Completion (Estimated) 30 August 2025
✅ Study Completion (Estimated) 30 August 2025
👥 Enrollment (Estimated) 24
🔬 Study Type INTERVENTIONAL
📊 Phase EARLY_PHASE1
Locations:
📍 New Haven, Connecticut, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Young women between the ages of 18 and 45 years (Controls);
    • * Young women between the ages of 18 and 45 years with endometriosis.

    Exclusion Criteria:

    • * Subjects who smoke
    • * Subjects who have diabetes,
    • * Subjects with sleep apnea or BP\>140/90 will be excluded.
    • * Women with endometriosis and severe acute pain requiring immediate treatment will be excluded.
Ages Eligible for Study: 18 Years to 45 Years (ADULT)
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 17 October 2018
  • First Submitted that Met QC Criteria 16 November 2018
  • First Posted 19 November 2018

Study Record Updates

  • Last Update Submitted that Met QC Criteria 20 June 2024
  • Last Update Posted 21 June 2024
  • Last Verified June 2024
I'm interested ...!!